Expertise: Payer Market Research, Payer Coverage and Restrictions
Dhvani Valia is an associate manager of Market Research at MMIT. She advices pharmaceutical clients on payer behavior and perspectives on marketed agents throughout their lifecycle, and supports pre-launch clients to help them understand potential payer coverage trends and barriers. She holds an MS in Biochemistery from the University of Mumbai and an MS in Entrepretneurial Biotechnology from Case Western Reserve University.
The Impact of Expedited Approvals on Payer Coverage
To speed patient access to potentially life-saving therapies, the FDA established expedited approval pathways for selected drugs that fill unmet needs or treat serious conditions. For patients in need, these pathways serve an essential purpose.
What Payers Want: Understanding Payer Preferences When Evaluating Therapies
Many manufacturers are interested in which factors can give them an edge on obtaining preferred coverage with payers. This is especially true given the increasing competition in saturated categories such as immunology, diabetes care and breast cancer.
